Teduglutide in Short Bowel Syndrome Patients: A Way Back to Normal Life? (JPEN 46.2)

Dr. Kelly Tappenden interviews Drs. Felix Harpain, Lukas Schlager, and Christopher Dawoud of the Department of General Surgery of the Medical University of Vienna, discussing the integrating SBS-IF patients treated with teduglutide in a proactive and tight-meshed patient care program significantly improves the clinical outcome, leading to an increased proportion of patients reaching enteral autonomy. The text included in the description of the podcast Business Corporate by Alex Menco | alexmenco.net Music promoted by www.free-stock-music.com Creative Commons Attribution 3.0 Unported License creativecommons.org/licenses/by/3.0/deed.en_US February 2022